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Value of immunohistochemistry in the diagnosis of malignant 
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The cervical lymph nodes are relevant due to the diversity of clinical entities. The use of 
immunohistochemistry is a real method to elucidate the diagnosis of adenopathy, both primary and 
metastatic neoplasms.
Objective: To assess the value of immunohistochemistry in the diagnosis of cervical lymph nodes 
malignancies.
Method: Retrospective study of the database histopathological specimens from 2009 to 2011.
Results: Out of 32 biopsies of cervical lymph nodes, in 16 (50%) the immunohistochemistry was 
employed, being 68.75% (11) in hematological neoplasms and 31.25% (5) in carcinomas. It was 
used in all cases of lymphoma.
Conclusion: The immunohistochemistry was used in 50% of the biopsies of lymph nodes under 
suspicion of malignancy, being 31.25% in epithelial lesions and 68.75% in lymphoproliferative lesions.
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INTRODUCTION
Reports of neck lymphadenopathies are 
described worldwide as one of the most common 
forms of peripheral manifestations of this disorder. 
The etiologies for this group of lesions are the most 
diverse, ranging from reactive states, infections, auto-
immune diseases, primary and secondary neoplasms1,2. 
Because of its etiological diversity, there is an age 
range of onset that can reach from the pediatric to 
the elderly patient.
Clinical research is extremely important in order 
to reach a more accurate diagnosis and to help decide 
which are the cases that require further and more 
specific investigation. Histological analysis is central 
to the assessment of these lymphadenopathies when 
clinical and/or radiological criteria alone are unable to 
establish a precise diagnosis, and especially in highly 
suspicious for malignancy cases. Histopathological 
evaluation is essential to establish both the histological 
type and its classification and thus, it is an important 
factor to help conceive and execute treatment. The 
difficulties in the histopathological analysis of biopsy 
specimens exist because of diagnostic variety and the 
pathologist experience.
The analysis and histological classification 
of tumors gained a few decades ago an important 
complementary technique with the advent of 
immunohistochemistry, promoting, over the years, 
its incorporation into routine diagnostic methods, 
facilitated thanks to improved technology, includ-
ing more efficient antigenic recovery protocols, 
improved markers, lower costs and easier use of 
paraffin material. With this technique we became 
more accurate in determining the histogenesis of 
malignant neoplastic lesions, especially in cases 
of poorly differentiated neoplasms, as well as for 
establishing and finding the primary site in cases 
of metastatic neoplasms. Poorly differentiated 
neoplasms are difficult to diagnose, and have 
divergent interexaminer diagnostic rates. The use 
of an accurate immunohistochemical panel is es-
sential to differentiate epithelial and mesenchymal 
cell lines3.
Metastasis in neck lymph nodes from squamous 
cell carcinoma is a common situation in cases of 
patients already diagnosed and treated for cancer of 
the head and neck, and it may as well be the first 
overt clinical manifestation. In general, squamous 
cell carcinoma, even the metastatic one, does not 
pose major histopathological diagnostic difficulties; 
however, in their less differentiated forms, it may raise 
diagnostic questions when only hematoxylin and eosin 
dyes are utilized.
We must not forget that immunohistochemistry 
brought about a diagnostic and prognostic revolu-
tion in the evaluation of primary neoplasms of the 
hematopoietic system4. The classification and identifi-
cation of lymphomas was positively impacted, and we 
started to add the method to daily diagnostic routine, 
which is presently a mandatory item in pathology 
reports.
We noticed a lack of reports which ana-
lyze the use of immunohistochemistry in the 
histopathological evaluation of lymph node biop-
sies of the head and neck. Thus, the revision of 
the present series aims to assess the need to use 
this technique to aid in routine diagnosis.
METHOD
This is a retrospective study carried out in the 
Registry Files of the Cancer Hospital (RHC) of the 
institution, from August 2009 to December 2011, 
based on the pathological results, being approved 
by the respective Research Ethics Committee under 
protocol # 170 (attached).
The inclusion criteria were: diagnosed cases of 
lymph node biopsies recorded at the RHC and which 
pathological results were filed in electronic media at 
the RHC. The exclusion criteria were: cases in which 
there was a diagnosis of squamous cell carcinoma in 
any sub-site of the head and neck.
Descriptive analysis was performed through the 
use of absolute and relative frequencies.
RESULTS
After a pathology study, we found 32 reported 
cases of lymph node biopsies for diagnostic purposes, 
no primary lesion diagnosed. Of the 32 cases, 53.13% 
(17) were in males and 48.88% (15) in females, aged 
23-85 years, with a mean of 52 years.
The most frequent histological cell lines found 
were lymphomas and squamous cell carcinomas 
(Table 1). Of the 32 cases, 16 were subjected to 
immunohistochemistry, most of which revealed that 
it was lymphoma (Table 2).
Lymphomas accounted for 68.75% (11) of 
the cases submitted to immunohistochemistry, and 
carcinomas for 31.25%5. Among the lymphomas, 
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Table 1. Distribution of histological cell lines (n = 32).
n %
Squamous cell carcinoma 9 28.13%
Adenocarcinoma 3 9.38%
Thyroid papilliferous carcinoma 2 6.25%
Acinic cell carcinoma 1 3.13%
Undifferentiated carcinoma 1 3.13%
Large B cells diffuse lymphoma 6 18.75%
Hodgkin’s lymphoma (classic) 1 3.13%
Hodgkin’s lymphoma (nodular sclerosis) 3 9.38%
Follicular lymphoma 1 3.13%
Lymphoid hyperplasias 4 12.5%
Hemangioma 1 3.13%
Table 2. Immunohistochemistry use according to histogenic 
cell lines.
With immuno-
histochemistry 
(n)
%
Without immuno-
histochemistry 
(n)
%
Lymphomas 11 34.38 0 0
Carcinomas 5 15.63 11 34.38
Others 0 0 5 15.63
Total 16 50 16 50
Table 3. Distribution of the number of cases submitted 
toimmunohistochemistry according to the histological cell 
line (n = 16).
Number of cases 
submitted to immuno-
histochemistry
%
Squamous cell carcinoma 0 0
Adenocarcinoma 3 18.75
Thyroid papilliferous carcinoma 1 6.25
Acinic cells carcinoma 0 0
Undifferentiated carcinoma 1 6.25
Large B cells diffuse lymphoma 6 37.5
Hodgkin’s lymphoma (classic) 1 6.25
Hodgkin’s lymphoma (nodular 
sclerosis) 3 18.75
Follicular lymphoma 1 6.25
Lymphoid hyperplasia 0 0
Hemangioma 0 0
Table 4. Distribution of the use of markers.
Marker Number of times utilized
34BE12 4
35BH11 4
CK7 5
CH20 3
CK5/6 3
AE1/AE3 2
CD3 13
CD5 3
CD15 8
CD20 13
CD23 2
CD30 9
CD45 1
BCl-2 6
Ki67 5
HMB45 1
Vimentin 1
Thyroglobulin 1
DISCUSSION
Enlarged lymph nodes in the neck of suspected 
neoplasia represent constitute an important clinical 
condition that requires proper diagnosis and treatment. 
Squamous cell carcinomas of the head and neck have 
a high risk of metastasis to regional lymph nodes and 
the confirmation of lymph node involvement has a 
direct impact on rates of disease control, with marked 
reduction in survival curves, requiring a correct 
diagnosis5.
In this study, we found that, of the 32 cases of 
lymph node biopsies, nine corresponded to squamous 
cell carcinoma, and of these, none had to be subjected 
to immunohistochemistry for diagnostic confirmation 
or establishing histogenic cell line. This value confirms 
the condition that the squamous cell carcinomas are, 
in most cases, lesions which, in their well differenti-
ated and moderately differentiated shapes, causes 
no doubts about their histopathological diagnosis. 
Still in this series, we had other lesions of epithelial 
histogenesis, and in seven cases, four were subjected 
to immunohistochemistry.
The literature does not have comparative 
studies regarding the use of immunohistochemistry 
in malignant neck lymphadenopathy; however, we 
found reports of evaluations considering only poorly 
differentiated lesions in lymph nodes, with agreement 
the most common subtype was the diffuse large B 
cell lymphoma; and among carcinomas it was the 
adenocarcinoma (Table 3).
Among the markers used in the immunohisto-
chemical battery, the most used were: CD3, CD20, 
CD30 and CD 15 (Table 4).
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rates confirming the diagnosis of carcinoma, with 
values ranging from 27 to 54%6. The major problem 
remains in the diagnosis of undifferentiated tumors 
present in 7.6% of head and neck cancer cases; and in 
this series we found 3.1%6. Thus, immunohistochem-
istry remains an important diagnostic tool for cases 
of poorly differentiated carcinomas in order to define 
histogenic cell lines7.
However, in this study, we found massive use 
of immunohistochemistry in lymphomas, accounting 
for 68.75% of its use. The classification of lymphomas 
in the past was only based on their morphological 
characteristics, evaluated by routine staining. However, 
as of the 80s, immunotyping techniques began to be 
used as a result of changing lymphoma diagnosis 
patterns8. Several classifications for lymphomas were 
based on new techniques and immunohistochemical 
markers that were emerging. Thus, we started having 
improved diagnostic approach to differentiate Hodg-
kin’s lymphoma, and B and T non-Hodgkin ones, as 
well as better characterization of subtypes9.
Due to the great diversity in the clinical course 
of lymphomas, its proper classification noticeably 
changes its treatment, having an effective impact 
on survival rates. Thus, these days, it is practically 
unthinkable to have diagnostic conclusion without 
immunohistochemistry confirmation. In this series, all 
lymphomas were subjected to immunohistochemistry, 
the majority being diagnosed as large B cells lym-
phoma, followed by Hodgkin’s lymphoma in the 
nodular sclerosis phase, a fact that coincides with the 
literature, in which the method was incorporated to 
all lymphoma cases10.
Still in this series, we found 12.5% of cases 
made up of reactive lymphoid hyperplasia and none 
was submitted to immunohistochemistry. The pres-
ence of benign lesions may bring about diagnostic 
questions and in such cases it may be necessary to 
use the method.
CONCLUSION
Immunohistochemistry was used in 50% 
of lymph node biopsies of cases suspicious for 
malignancy, the use in epithelial cell line lesions oc-
curred at 31.25% and 68.75% in hematopoietic cell 
lines, immunohistochemistry was used in 100% of the 
lymphoma cases.
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